Skip to content

Diminished the postoperative delirium in patients following microvascular decompression by Huperzine-A injection: a single-center, open controlled trial

Diminished the postoperative delirium in patients following microvascular decompression by Huperzine-A injection: a single-center, open controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034272
Enrollment
Unknown
Registered
2020-06-30
Start date
2020-06-21
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

control group:physiological saline injection

Sponsors

Xinhua Hospital Affilated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 65 years, regardless of gender; 2. Conforming to the patient in MVD indication in condition of general anesthesia; 3. Patient agrees to participate in the trial, and he or his legal guardian signs the consent before the trial.

Exclusion criteria

Exclusion criteria: 1. Preoperative MMSE scores were < 23; 2. Liver or kidney dysfunction; 3. Disease of the central nervous system; 4. History of mental illness, long-term use of sedatives or antidepressants, etc.; 5. History of alcohol or drug abuse; 6. Serious systemic diseases, especially circulation system diseases, such as myocardial infarction, heart failure, unstable angina pectoris, history of sinus bradycardia; 7. Patients are intolerant of experiment or cooperate with the examination, aphasia or audiovisual function obstacle; 8. Be allergic to Hup A; 9. Other clinical trials were conducted within 3 months prior to the study.

Design outcomes

Primary

MeasureTime frame
Delirium rating scale;

Secondary

MeasureTime frame
CAM-ICU;MMSE;NPI;

Countries

China

Contacts

Public ContactShiting Li

Xinhua Hospital Affilated to Shanghai Jiaotong University School of Medicine

lishiting@xinhuamed.com.cn+86 13701625911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026